ArticleInternational journal of oncology2022

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines.

André Fedier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.